ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,455, issued on May 19, was assigned to CHAMEDITECH Co. LTD. (Daejeon, South Korea).
"Hyaluronic acid-based hydrogel using peptide crosslinking agent, and method for producing same" was invented by Kyeong-Yong Park (Daejeon, South Korea), Jun-Goo Kang (Cheongju-si, South Korea), Seoung Jin Lee (Daejeon, South Korea) and Sok Jin Kim (Gunpo-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a hyaluronic acid-based hydrogel which is a hyaluronic acid-peptide crosslinked body crosslinked using a peptide crosslinking agent. More specifically, the present invention relates to a hyaluronic acid-based hydrogel and ...